Loading compare…
7 funds hold both · as on May 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 7 mutual funds hold active equity positions in both Aarti Drugs and Alembic Pharmaceuticals. The scheme with the highest combined exposure is DSP Healthcare Fund (DSP MF), which holds a 0.98% stake in Aarti Drugs and a 3.21% stake in Alembic Pharmaceuticals, amounting to a combined conviction weight of 4.19%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Aarti wt. | Alembic wt. | Combined |
|---|---|---|---|
| DSP Healthcare FundDSP MF · Sectoral / Thematic | 0.98% | 3.21% | |
| ICICI Prudential Pharma Healthcare and Diagnostics FundICICI Pru MF · Sectoral / Thematic | 1.10% | 1.76% | |
| DSP Small Cap FundDSP MF · Small Cap | 1.32% | 0.60% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.16% | 0.52% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.09% | 0.30% | |
| IB18-Groww Nifty Total Market Index FundGroww MF · Index Fund | 0.01% | 0.02% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.01% | 0.02% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on May 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.